NasdaqGM - Nasdaq Real Time Price USD

Lantheus Holdings, Inc. (LNTH)

63.07 -0.74 (-1.16%)
At close: April 22 at 4:00 PM EDT
64.89 +1.82 (+2.89%)
After hours: April 22 at 5:21 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,296,429.00
1,296,429.00
935,061.00
425,208.00
339,410.00
Cost of Revenue
586,886.00
586,886.00
353,358.00
237,513.00
200,649.00
Gross Profit
709,543.00
709,543.00
581,703.00
187,695.00
138,761.00
Operating Expense
344,901.00
344,901.00
545,508.00
263,783.00
142,959.00
Operating Income
364,642.00
364,642.00
36,195.00
-76,088.00
-4,198.00
Net Non Operating Interest Income Expense
-381.00
-381.00
-4,572.00
-7,707.00
-9,241.00
Other Income Expense
46,682.00
46,682.00
-4,904.00
8,757.00
1,960.00
Pretax Income
410,943.00
410,943.00
26,719.00
-75,038.00
-11,479.00
Tax Provision
84,282.00
84,282.00
-1,348.00
-3,759.00
1,994.00
Net Income Common Stockholders
326,661.00
326,661.00
28,067.00
-71,279.00
-13,473.00
Diluted NI Available to Com Stockholders
326,661.00
326,661.00
28,067.00
-71,279.00
-13,473.00
Basic EPS
1.53
4.79
0.41
-1.06
-0.25
Diluted EPS
1.50
4.65
0.40
-1.06
-0.25
Basic Average Shares
68,266.50
68,266.00
68,487.00
67,486.00
54,134.00
Diluted Average Shares
70,370.25
70,239.00
70,671.00
67,486.00
54,134.00
Total Operating Income as Reported
364,642.00
364,642.00
36,195.00
-60,825.00
-4,198.00
Total Expenses
931,787.00
931,787.00
898,866.00
501,296.00
343,608.00
Net Income from Continuing & Discontinued Operation
326,661.00
326,661.00
28,067.00
-71,279.00
-13,473.00
Normalized Income
289,439.53
289,439.53
31,941.16
-79,598.15
-14,902.34
Interest Income
19,638.00
19,638.00
2,613.00
45.00
238.00
Interest Expense
20,019.00
20,019.00
7,185.00
7,752.00
9,479.00
Net Interest Income
-381.00
-381.00
-4,572.00
-7,707.00
-9,241.00
EBIT
430,962.00
430,962.00
33,904.00
-67,286.00
-2,000.00
EBITDA
491,005.00
491,005.00
81,833.00
-24,998.00
22,689.00
Reconciled Cost of Revenue
586,886.00
586,886.00
353,358.00
237,513.00
200,649.00
Reconciled Depreciation
60,043.00
60,043.00
47,929.00
42,288.00
24,689.00
Net Income from Continuing Operation Net Minority Interest
326,661.00
326,661.00
28,067.00
-71,279.00
-13,473.00
Total Unusual Items Excluding Goodwill
46,825.00
46,825.00
-4,904.00
8,757.00
1,958.00
Total Unusual Items
46,825.00
46,825.00
-4,904.00
8,757.00
1,958.00
Normalized EBITDA
444,180.00
444,180.00
86,737.00
-33,755.00
20,731.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
9,603.53
9,603.53
-1,029.84
437.85
528.66
12/31/2020 - 6/25/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AMPH Amphastar Pharmaceuticals, Inc.
40.17
+0.40%
 
NBIX Neurocrine Biosciences, Inc.
133.66
+1.26%
 
SIGA SIGA Technologies, Inc.
8.35
+0.12%
 
ITCI Intra-Cellular Therapies, Inc.
74.54
+3.00%
 
ZTS Zoetis Inc.
145.54
-0.66%
 
ESPR Esperion Therapeutics, Inc.
1.9100
-2.05%
 
EOLS Evolus, Inc.
11.72
+1.65%
 
DVAX Dynavax Technologies Corporation
11.84
+0.34%
 
COLL Collegium Pharmaceutical, Inc.
34.74
-0.29%
 
EVO Evotec SE
7.36
+4.10%